The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Repros Therapeutics Inc.  (RPRX) Trade Now »     Rate RPRX  -  Discuss RPRX  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate RPRX:



RPRX Analysis & Videos »


RPRX: Bull or Bear?

Repros Therapeutics Inc. Graphic_rating_buy RPRX
Foto
62%
 -42.31%
in 29 days
<> <> <> On 5/11/09, RPRX reported that its Proellex clinical programs are progressing well and according to plan. RPRX completed enrollment of its first Pivotal Phase 3 clinical trial (ZPU-303) for the chronic treatment of uterine fibroids and expect the first Pivotal Phase 3 clinical trial for the treatment of anemia associated with uterine fibroids (ZPU-301), to be fully enrolled mid-2009, which would then lead to top-line results in each study by the end of this year. RPRX expects top-line results from its other two complementary Pivotal Phase 3 studies, ZPU-302 (anemia) and ZPU-304 (chro...
By  Marian Filo   (-24.55%  risk: aggressive)  06/10/09 Comment


BioMedReports.com Extreme Trades: ACAD, ANPI, BSTC, RPRX, SNTS Graphic_rating_buy RPRX
Mikerun
73%
 -43.16%
in 30 days
<> Below are four companies with market caps under $200 million (all financial data current as of 6/9/09 during intraday trading) which have pending FDA decisions and/or clinical trial results that may have a major impact on each of the underlying stock prices. A high risk/reward trading approach to consider for speculative traders is investing a small amount of money that you can afford to lose in a basket of stocks included in <font> Extreme FDA and Clinical Trial Calendar Trades </font> , which are highlighted in periodic articles at BioMedReports.com. Another approach is to simply bu...
By  Mike Havrilla   (+1.04%  risk: conservative)  06/09/09 Comment





People Bullish on RPRX

Foto
Marian Filo
Principal
62%
29 days ago

Mikerun
Mike Havrilla
Principal
73%
about 1 mo ago

Me
Rui Araújo
Associate
41%
11 mos ago

beth1lee
Analyst
86%
over 2 years ago


People Bearish on RPRX

ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +42.42% 274
2 Gerald Greene 18.14 +54.81% 140
3 stockmarketfunding.com 17.66 +22.12% 35
4 akiralegrand 13.47 +15.91% 49
5 anup2104 12.13 +34.41% 13


POPULAR STOCKS
Symbol Company Name Sentiment
SIRI Sirius Satellite Radio Inc
EBAY eBay Inc
MA MasterCard Inc
FSLR First Solar Inc.
WM Washington Mutual Inc
AAPL Apple Computer Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on RPRX


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About Repros Therapeutics Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch